Sign in
LSBCF Stock Price, Chart, Stats & News
LakeShore Biopharma Co., Ltd
Save
LakeShore Biopharma Co., Ltd (LSBCF) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
LSBCF chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 82.47% |
Operating margin | -14.03% |
Pretax margin | -16.41% |
Net margin | -16.26% |
Effective tax rate | 0.94% |
ROA | -7.31% |
ROE | -18.43% |
D/E | 0.83x |
Interest coverage ratio | -5.48x |
LSBCF valuation
P/E | – |
P/S | 0.02x |
P/B | 0.07x |
P/CF | -0.27x |
P/FCF | -0.09x |
P/OCF | -0.27x |
PEG | -0.00x |
EV multiple | 7.69x |
About
LakeShore Biopharma Co., Ltd (LSBCF) is a biopharmaceutical firm dedicated to the end-to-end process of bringing innovative medical solutions to market. Its primary focus lies in creating vaccines and advanced therapeutic biologics, specifically designed to combat infectious diseases and various forms of cancer. A cornerstone of its strategy is the proprietary PIKA immunomodulating technology platform.
Similar securities
Based on sector and market capitalization
Report issue